Join
Live feed
·
PRReleasevia Quantisnow
Biocept Inc. logo

Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept's CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases

ByQuantisnow·Wall Street's wire, on your screen.
BIOC· Biocept Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIOC (Biocept Inc.) and more on Quantisnow.